Relative Bioavailability Study of HNC364 Injectable Suspension

Clinical trial NCT06798519 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT06798519
Sponsor: Guangzhou Henovcom Bioscience Co. Ltd.
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Parkinson's Disease (PD)

Start date: 2026-05-08
Primary completion: 2026-12-31
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.